Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.70 Insider Own26.20% Shs Outstand51.65M Perf Week-13.41%
Market Cap279.56M Forward P/E- EPS next Y-1.67 Insider Trans0.00% Shs Float41.51M Perf Month-1.00%
Income-79.79M PEG- EPS next Q-0.39 Inst Own58.19% Short Float4.81% Perf Quarter6.42%
Sales0.00M P/S- EPS this Y21.90% Inst Trans0.09% Short Ratio3.11 Perf Half Y132.24%
Book/sh1.99 P/B2.50 EPS next Y-13.73% ROA-57.38% Short Interest2.00M Perf Year176.11%
Cash/sh2.05 P/C2.43 EPS next 5Y- ROE-78.81% 52W Range1.62 - 7.66 Perf YTD76.87%
Dividend Est.- P/FCF- EPS past 5Y-49.79% ROI-63.49% 52W High-35.12% Beta2.50
Dividend TTM- Quick Ratio7.05 Sales past 5Y0.00% Gross Margin- 52W Low206.79% ATR (14)0.48
Dividend Ex-Date- Current Ratio7.05 EPS Y/Y TTM28.39% Oper. Margin0.00% RSI (14)39.90 Volatility7.30% 8.85%
Employees54 Debt/Eq0.24 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price12.60
Option/ShortYes / Yes LT Debt/Eq0.20 EPS Q/Q38.52% Payout- Rel Volume1.45 Prev Close4.90
Sales Surprise- EPS Surprise19.41% Sales Q/Q- EarningsMay 09 BMO Avg Volume641.17K Price4.97
SMA20-16.10% SMA50-7.40% SMA20036.47% Trades Volume930,135 Change1.43%
Date Action Analyst Rating Change Price Target Change
Jul-14-23Initiated Piper Sandler Overweight
Jun-30-23Upgrade Stifel Hold → Buy $2 → $10
Jun-28-23Upgrade H.C. Wainwright Neutral → Buy $11
Jun-27-23Upgrade Wedbush Neutral → Outperform $10
Mar-29-22Downgrade Wedbush Outperform → Neutral
Mar-22-22Downgrade H.C. Wainwright Buy → Neutral
Sep-30-21Initiated Stifel Hold $10
Jan-07-21Initiated Wedbush Outperform $45
Nov-24-20Initiated Berenberg Buy $58
May-04-20Initiated H.C. Wainwright Buy $53
May-16-24 08:23AM
May-10-24 08:46AM
May-09-24 01:54PM
08:50AM Loading…
Apr-29-24 08:50AM
Apr-25-24 09:55AM
Apr-24-24 04:05PM
Apr-23-24 07:45AM
Apr-15-24 12:00PM
Apr-11-24 08:00AM
Apr-08-24 09:55AM
Apr-07-24 06:00PM
Apr-03-24 08:00AM
Mar-22-24 09:55AM
05:31AM Loading…
Mar-14-24 05:31AM
Mar-12-24 08:32AM
Mar-05-24 04:30PM
Feb-28-24 08:00AM
Jan-04-24 08:00AM
Dec-13-23 07:00AM
Nov-07-23 08:00AM
Nov-06-23 08:07AM
Oct-20-23 12:54PM
Oct-14-23 12:30PM
Oct-04-23 12:14PM
Sep-18-23 12:34PM
07:00AM Loading…
Sep-11-23 08:00AM
Sep-05-23 08:00AM
Aug-17-23 09:56AM
Aug-11-23 07:35AM
Jul-25-23 07:43AM
Jul-16-23 10:05AM
Jun-29-23 08:57PM
Jun-28-23 04:23PM
Jun-27-23 07:00AM
Jun-13-23 08:00AM
Jun-02-23 08:00AM
May-18-23 10:17AM
May-09-23 07:46AM
Apr-18-23 08:00AM
Apr-17-23 04:01PM
Mar-09-23 07:52AM
Feb-27-23 08:00AM
Feb-15-23 05:46AM
Jan-19-23 05:41AM
Jan-05-23 08:00AM
Dec-19-22 08:00AM
Dec-12-22 08:00AM
Dec-09-22 09:35AM
Nov-09-22 08:00AM
Nov-08-22 08:00AM
Oct-26-22 08:00AM
Sep-06-22 08:00AM
Aug-28-22 09:41AM
Aug-09-22 08:00AM
Aug-03-22 08:00AM
Aug-01-22 08:55AM
Jul-02-22 08:29AM
Jun-06-22 08:00AM
Jun-01-22 07:00AM
May-17-22 07:00AM
May-12-22 04:30PM
May-11-22 04:30PM
Apr-28-22 12:52PM
Apr-25-22 09:00AM
Apr-18-22 07:00AM
Apr-07-22 04:30PM
Mar-17-22 05:00PM
Mar-02-22 08:00AM
Feb-22-22 08:00AM
Feb-16-22 05:28AM
Jan-11-22 07:00AM
Jan-10-22 07:00AM
Jan-05-22 08:00AM
Nov-18-21 05:27AM
Nov-08-21 04:05PM
Oct-08-21 04:05PM
Oct-04-21 11:02AM
Sep-30-21 04:35PM
Sep-21-21 04:05PM
Aug-12-21 08:22AM
Aug-10-21 07:45AM
Aug-04-21 07:45AM
Aug-02-21 02:26AM
Jul-29-21 03:53PM
May-19-21 05:00PM
Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BIOTECH GROWTH N V10% OwnerOct 17 '23Buy2.34400,000934,0808,517,839Oct 19 03:08 PM
Behbahani AliDirectorJul 05 '23Buy5.001,000,0005,000,0004,448,757Jul 06 04:45 PM
RA CAPITAL MANAGEMENT, L.P.DirectorJul 05 '23Buy5.00935,8504,679,2503,213,828Jul 07 04:30 PM
BIOTECH GROWTH N V10% OwnerJun 30 '23Buy5.001,000,0005,000,0008,117,839Jul 03 03:36 PM
BIOTECH GROWTH N V10% OwnerJun 27 '23Buy5.491,740,0009,555,0367,117,839Jun 29 01:37 PM
Epstein David M.SEE REMARKSJun 27 '23Sale6.7025,000167,500671,423Jun 28 04:02 PM